Communicable Diseases Prevention and Control Act

Passed 12.02.2003
RT I 2003, 26, 160
entry into force in accordance with § 54.

Chapter 1 GENERAL PROVISIONS  

§ 1.  Scope of application of Act

 (1) This Act regulates the way in which the control of communicable diseases is organised and the procedure for the provision of health care services to infected persons (hereinafter provision of medical care), and sets out the obligations of the state, local governments, legal persons and natural persons in the prevention and control of communicable diseases.

 (2) This Act applies to all natural persons in the territory of the Republic of Estonia and to legal persons located in the territory of the Republic of Estonia unless otherwise provided by an international agreement or international convention.

 (3) The provisions of the Administrative Procedure Act apply to administrative proceedings prescribed in this Act, taking account of the specifications provided for in this Act.

§ 2.  Definitions

  In this Act, the following definitions are used:
 1) “infectious agent” means a prion, virus, bacterium, microscopic fungus, protozoan, helminth or arthropod, and their components and toxins capable of causing communicable diseases;
 2) “communicable disease” means a disease, or carrier state with no signs of disease, which is caused by the entry of an infectious agent into the human body which is transmitted or with regard to which there is reason to believe that it may be transmitted directly or indirectly person-to-person or animal-to-person;
 3) “extremely dangerous communicable disease” means a disease with a high level of infectiousness which spreads rapidly and extensively or which is serious or life-threatening. For the purposes of this Act, the plague, cholera, yellow fever, viral hemorrhagic fevers and tuberculosis are extremely dangerous communicable diseases;
 4) “person suffering from a communicable disease” means a person who has been diagnosed as having a communicable disease using methods accepted by medical science;
 5) “ person suspected of being infected” means a person who has been exposed to similar conditions as a person suffering from a communicable disease or who may have been infected by a person suffering from a communicable disease but who has not developed any symptoms of disease by the time he or she undergoes a medical examination;
 6) “control of communicable diseases” means the application of health protection measures which enable the early detection and consequent testing and treatment of persons suffering from communicable diseases and of persons suspected of being infected in order to ascertain the causes and mode of their infection, prevent the spread of the communicable disease and prevent healthy persons from being infected;
 7) “epidemic” means an outbreak of a communicable disease which calls for infection control measures to be applied extensively;
 8) “surveillance” means systematic collection, analysis, interpretation and dissemination of health data, including epidemiological studies of communicable diseases and risk factors for contracting communicable diseases for the purpose of prevention of the spread and control of communicable diseases;
[RT I 2009, 49, 331 – entry into force 01.01.2010]
 9) “disease outbreak” means the occurrence of cases of communicable disease connected with the same source of infection or spread factor in excess of what would normally be expected within a certain period.
[RT I 2009, 49, 331 – entry into force 01.01.2010]

Chapter 2 PROVISION OF MEDICAL CARE TO PERSONS SUFFERING FROM COMMUNICABLE DISEASE  

§ 3.  Consent for provision of medical care

 (1) Medical care shall be provided to a person suffering from a communicable disease or to a person suspected of being infected with his or her consent.

 (2) Medical care shall be provided to a person with restricted active legal capacity with the consent of his or her legal representative based on his or her will in so far as the person is able to express such will. Emergency care may be provided to a patient without the consent of his or her legal representative or without the person’s will if failure to do so might endanger the life of the patient or cause significant damage to his or her health. Third parties shall not prohibit or prevent the provision of emergency care.
[RT I 2008, 59, 330 – entry into force 01.01.2009]

§ 4.  Involuntary treatment of persons suffering from communicable disease

 (1) In order to prevent the spread of extremely dangerous communicable diseases, a person suffering from such disease may be hospitalised without his or her consent if the person is dangerous to others and has refused treatment or violated the treatment regime.

 (2) The decision to apply involuntary treatment shall be made by a physician on the basis of a medical examination of the person, initial analysis or radiography findings.

 (3) The procedure for deciding on the application of involuntary treatment shall be established by a regulation of the minister responsible for the area. The decision shall set out the reasons for applying involuntary treatment with a reference to the relevant provision of law.

 (4) The physician shall immediately inform the person suffering from a communicable disease of the decision to apply treatment to him or her and shall inform the person close to or the legal representative of the person within forty-eight hours as of the decision being taken.

 (5) A person suffering from a communicable disease or a person authorised by him or her shall arrange for his or her property to be protected.
[RT I, 04.12.2015, 1 – entry into force 14.12.2015]

 (6) On the basis of a decision specified in subsection (2) of this section, a health care provider may, where necessary, use the assistance of the police to transfer a person suffering from a communicable disease to hospital, in which case the health care provider shall provide the police officers with appropriate protective equipment in conformity with the communicable disease control requirements provided in § 22 of this Act and instruct them in the proper use of such equipment.
[RT I 2005, 39, 308 – entry into force 01.01.2006]

 (7) A health care provider shall, at the first opportunity, notify the police of a person suffering from an extremely dangerous communicable disease, who is dangerous to others, who has refused treatment or violated the treatment regime and whose location is unknown, by forwarding a copy of the decision pursuant to subsection (3) of this section to the police.
[RT I, 04.12.2015, 1 – entry into force 14.12.2015]

 (8) The police shall promptly notify the health care provider having submitted the decision to apply involuntary treatment if the location of the person specified in subsection (7) of this section has been ascertained. The health care provider shall organise the application of involuntary treatment to the person suffering from a communicable disease and, if necessary, the extension thereof in accordance with this Act.
[RT I, 04.12.2015, 1 – entry into force 14.12.2015]

§ 5.  Conditions and procedure for application of involuntary treatment

 (1) The application, extension and termination of involuntary treatment shall be decided by court pursuant to the procedure prescribed for the proceeding for placement of the person in a closed institution provided for in the Code of Civil Procedure unless otherwise provided by this Act.
[RT I 2005, 39, 308 – entry into force 01.01.2006]

 (2) On the basis of the decision of a physician, a person may be subjected to involuntary treatment within forty-eight hours as of his or her hospitalisation.
[RT I 2005, 39, 308 – entry into force 01.01.2006]

 (3) Involuntary treatment may continue for a period longer than forty-eight hours only based on a ruling of a county court granted on the basis of an application by the medical director of the corresponding hospital to which the decision of a physician specified in subsection 4 (2) has been appended. Involuntary treatment may be applied by a court also on the basis of an application by a legal representative of the person.
[RT I 2008, 59, 330 – entry into force 01.01.2009]

 (4) Involuntary treatment applied on the basis of permission granted by a court may continue for up to fourteen calendar days as of the date on which the court receives the corresponding application, although in the event of a case of tuberculosis, involuntary treatment on the basis of such permission may continue for up to 182 calendar days. If necessary, the court may extend the treatment by the same term on the basis of an application by a hospital or legal representative of the person.
[RT I 2008, 59, 330 – entry into force 01.01.2009]

 (5) A court shall review an application submitted for the grant of permission immediately and shall decide to grant or to refuse to grant permission. A court may refuse to hear a person suffering from a communicable disease in case of good reason.
[RT I 2005, 39, 308 – entry into force 01.01.2006]

 (6) [Repealed – RT I, 04.12.2015, 1 – entry into force 14.12.2015]

 (7) After the circumstances specified in subsection 4 (1) of this Act have ceased to exist, the medical director of the hospital shall submit an application to the court for termination of involuntary treatment of a person suffering from a communicable disease. The court may terminate treatment also based on an application by a legal representative of the person or upon own initiative.
[RT I 2008, 59, 330 – entry into force 01.01.2009]

 (8) A person suffering from a communicable disease who is hospitalised for involuntary treatment shall be placed in an isolated ward which meets the requirements for safety from infection. A person suffering from a communicable disease may leave the ward only under the conditions established in the relevant hospital instructions and only if measures to ensure safety from infection have been applied. Communication may be restricted for the person in so far as this is necessary to prevent the infection from spreading.
[RT I 2005, 39, 308 – entry into force 01.01.2006]

§ 6.  Duties of health care professionals upon prevention and control of communicable diseases

  [RT I, 04.12.2015, 1 – entry into force 14.12.2015]

 (1) A health care professional for the purposes of subsection 3 (1) of the Health Services Organisation Act shall:
[RT I, 04.12.2015, 1 – entry into force 14.12.2015]
 1) comply with the requirements set out in this Act for the prevention and control of communicable diseases;
 2) administer medical examinations to persons suffering from a communicable disease and to persons suspected of being infected, forward testing material to a laboratory for analysis if necessary, and prescribe treatment to the persons;
 3) determine the time when a person suffering from a communicable disease became infected, ascertain the source and mode of the infection and the factors of transmission of the infection, and identify the persons who have been in contact with the person suffering from the communicable disease;
 4) notify the persons who have been in contact with a person suffering from a communicable disease of the need for medical examinations;
[RT I, 04.12.2015, 1 – entry into force 14.12.2015]
 5) in the case of a communicable disease subject to registration, inform the Health Board of a suspicion of any suspected cases of the communicable disease, of diagnosis of the disease, of the circumstances under which the person suffering from the disease became infected and of the laboratory test findings pursuant to the procedure provided in § 21 of this Act;
 6) inform a person suffering from a communicable disease, or his or her legal representative, of the communicable nature of the disease, the route of transmission of the disease, the consequences of the disease remaining untreated and the restrictions to be applied with regard to the person pursuant to law, and instruct the patient in how to prevent the infection spreading. The health care professional shall make an entry in the person’s medical file concerning the information communicated to him or her;
[RT I, 04.12.2015, 1 – entry into force 14.12.2015]
 7) in the case of a sexually transmitted disease, issue a notice to the person suffering from the communicable disease which indicates the name of the disease and the need to inform persons who have been in sexual contact with the patient of the occurrence of the disease and of the necessity to undergo medical examination.

 (2) [Repealed - RT I, 04.12.2015, 1 – entry into force 14.12.2015]

 (3) [Repealed - RT I, 04.12.2015, 1 – entry into force 14.12.2015]

Chapter 3 PREVENTION OF SPREAD OF COMMUNICABLE DISEASES  

§ 7.  Principles of prevention of spread of communicable diseases

  In order to prevent the spread of communicable diseases, the immunisation of persons shall be organised, medical examinations shall be carried out and other measures to ensure safety from infection shall be applied.

§ 8.  Organising immunisation

 (1) The Ministry of Social Affairs shall coordinate the implementation of the immunisation schedule, immunisation pursuant to the procedure of emergency care, and the immunisation necessary for the prevention of an epidemic spread of communicable diseases.
[RT I, 04.12.2015, 1 – entry into force 14.12.2015]

 (1¹) Family physicians shall:
 1) organise immunisation on the basis of the immunisation schedule;
 2) ensure that the persons entered in his or her list have access to immunisation or refer them to another health care provider for immunisation, if necessary.
[RT I, 04.12.2015, 1 – entry into force 14.12.2015]

 (1²) The functions of a family physician specified in clause (1¹) 1) of this Act shall be performed by a family nurse, school health care provider or midwife if he or she complies with the requirements provided for in the regulation established under subsection (5) of this section.
[RT I, 04.12.2015, 1 – entry into force 14.12.2015]

 (2) Health care professionals organising immunisations shall:
 1) ascertain the temporary and permanent contraindications of the immunisation;
 2) maintain records of the immunisations carried out according to the requirements provided for in subsection 4² (2) and § 59² of the Health Services Organisation Act and in the regulation established under subsection (5) of this section;
 3) submit the immunisation reports to the Health Board according to the requirements provided for in the regulation established under subsection (5) of this section;
 4) register the adverse events of immunisations and notify the State Agency of Medicines thereof on the basis and pursuant to the procedure provided for in the Medicinal Products Act.
[RT I, 04.12.2015, 1 – entry into force 14.12.2015]

 (2¹) If a nurse or midwife organises the immunisation specified in subsection (2) of this section, he or she shall involve a physician to confirm any permanent contraindications or to diagnose any adverse events of immunisation.
[RT I, 04.12.2015, 1 – entry into force 14.12.2015]

 (3) [Repealed - RT I, 04.12.2015, 1 – entry into force 14.12.2015]

 (4) Additional immunisation of servicemen sent on missions abroad shall be organised by the Ministry of Defence as necessary.

 (5) The requirements for organising immunisation shall be established by a regulation of the minister responsible for the area.

 (6) In order to preserve the quality, safety and efficiency of immunological preparations, the functioning of the cold chain must be ensured in all stages of handling. Ensuring the requirements of the cold chain of immunological preparations upon the preservation and transportation thereof shall be effected on the basis and pursuant to the procedure provided for in § 34 of the Medicinal Products Act.
[RT I, 04.12.2015, 1 – entry into force 14.12.2015]

§ 9.  Immunisation in case of epidemic

 (1) If it is necessary in order to prevent the epidemic spread of a communicable disease, immunisation may be organised for persons at risk.

 (2) In case of an epidemic, the minister responsible for the area shall have the right to establish the appropriate code of conduct for the immunisation of persons at risk.
[RT I, 04.12.2015, 1 – entry into force 14.12.2015]

§ 10.  Immunisation schedule

  [RT I, 04.12.2015, 1 – entry into force 14.12.2015]

 (1) [Repealed - RT I, 04.12.2015, 1 – entry into force 14.12.2015]

 (2) The immunisation schedule sets out the communicable diseases immunised against, the age groups to be immunised and the terms of immunisation.

 (3) The immunisation schedule shall be established by a regulation of the minister responsible for the area.

§ 11.  Monitoring of immunity background

 (1) The immunity background is the proportion of persons in the population who are immune to a specific disease. The immunity background is monitored by way of health examinations.

 (2) [Repealed - RT I, 04.12.2015, 1 – entry into force 14.12.2015]

§ 12.  Screening of pregnant women for communicable diseases and carrier states

 (1) Pregnant women shall be screened for syphilis, hepatitis B and HIV in order to prevent the transmission of communicable diseases to the embryo or foetus or to the new-born child.

 (2) The procedure for screening and treating pregnant women shall be established by a regulation of the minister responsible for the area.

§ 13.  Medical examination of employees

 (1) Employers are required to demand the submission of a written health certificate concerning the passing of a medical examination for communicable diseases before the commencement of employment and to send the following employees for regular re-examination during their period of employment according to the results of risk assessment, including to the radiological examination of lungs in every two years:
 1) employees who handle food or drinking water or employees who, upon performance of their duties, come into contact with food or the handling equipment thereof, and employees who clean the food handling facilities;
 2) teachers, educators and other employees who, due to their duties, are in direct contact with children and adolescents;
 3) health care professionals, welfare workers and rescue workers who are in direct contact with patients, persons under curatorship or persons requiring care;
 4) the service staff of establishments providing accommodation, swimming and pool services and service staff engaged in the provision of beauty and personal treatments and personal services;
 5) persons who prepare, package or sell medicinal products;
 6) police officers and prison officers who, due to their duties, are in direct contact with prisoners or detained persons;
 7) school pupils, students and employees undergoing practical training or in-service training in the fields of activity listed in clauses 1)–6) of this section.
[RT I 2007, 1, 1 – entry into force 01.02.2007]

 (2) An employee shall submit to the employer a written health certificate concerning the passing of a medical examination for communicable diseases which shall be retained by the employer for at least three years.
[RT I 2007, 1, 1 – entry into force 01.02.2007]

 (3) Employers and sole proprietors staying and operating in the area specified in subsection (1) of this section in which there is the risk of direct or indirect transmission of any communicable disease, shall undergo regular medical examinations and hold a health certificate concerning the passing of medical examination for communicable diseases.
[RT I 2007, 1, 1 – entry into force 01.02.2007]

 (4) Family physician shall perform medical examinations for communicable diseases and issue a written health certificate concerning the passing of a medical examination for communicable diseases, the format of which shall be established by a regulation of the minister responsible for the area.
[RT I 2007, 1, 1 – entry into force 01.02.2007]

§ 14.  Ensuring safety of blood donation from infection

 (1) In order to protect donors and recipients, the Blood Centre and health care providers shall apply measures to ensure safety from infection.

 (2) The Blood Centre or the health care provider shall prepare a document recording the preparation and use of blood products, in compliance with the requirements provided for in the Blood Act (RT I 2005, 13, 63) and in the legislation established on the basis thereof.

 (3) The procedure for screening donated blood and blood components for infectious agents shall be established by a regulation of the minister responsible for the area.
[RT I 2005, 13, 63 – entry into force 01.05.2005]

§ 15.  Ensuring safety of procurement, handling and transplantation of cells, tissues and organs from infection

  [RT I, 26.02.2015, 1 - entry into force 01.03.2015]

 (1) In order to protect recipients and live donors, health care providers shall apply measures to ensure safety from infection.

 (2) A health care provider shall prepare a document recording the use of cells, tissues and organs.

 (3) The conditions of and procedure for screening donors for infectious agents shall be established by a regulation of the minister responsible for the area.
[RT I, 26.02.2015, 1 - entry into force 01.03.2015]

§ 16.  Avoiding infection while travelling abroad

  Undertakings which provide tourism services shall inform their customers about to travel to a foreign country of:
 1) the risks of becoming infected with a communicable disease in the country to be visited;
 2) the feasibility of immunisation or of using medicinal products;
 3) the possibility of obtaining medical advice before the trip and medical assistance during the trip and of the need for a medical examination following the trip.

Chapter 4 ORGANISATION OF SURVEILLANCE AND CONTROL OF COMMUNICABLE DISEASES  

§ 17.  Obligations of state upon surveillance and control of communicable diseases

  [RT I 2009, 49, 331 – entry into force 01.01.2010]

 (1) At state level, the surveillance and control of communicable diseases is organised by the Ministry of Social Affairs which performs the duties prescribed in the Public Health Act and directs activities to control communicable diseases.
[RT I 2009, 49, 331 – entry into force 01.01.2010]

 (2) Ministries shall act pursuant to this Act and legislation established on the basis thereof in applying measures for the prevention of communicable diseases and of the spread of such diseases and in organising medical care in the agencies in their area of government.

 (3) The Ministry of Justice and the Ministry of the Interior shall organise provision of the following in penal institutions and in police detention houses and detention cells respectively:
 1) working conditions which are as safe from infection as possible for prison officers, health care professionals and persons who are in direct contact with detained persons, persons in custody and prisoners;
 2) conditions of detention which are as safe from infection as possible for detained persons, persons in custody and prisoners;
 3) mandatory medical examinations, for epidemiological reasons, of prisoners who, due to the particular nature of their activities, may transmit communicable diseases through contact with food, water or other vectors and fomites;
 4) in order to prevent the spread of tuberculosis, mandatory radiographic examinations of lungs of detained persons, persons in custody and prisoners and of prison officers, guards and health care professionals in direct contact with them. The procedure for administering radiographic examinations shall be established by a regulation of the minister responsible for the area.

 (4) The Ministry of Justice and the Ministry of the Interior shall ensure conditions which are as safe from infection as possible during the transport of detained persons, persons in custody and prisoners.

 (5) The Ministry of Justice shall authorise health protection officials to exercise supervision over the application of measures to control communicable diseases in penal institutions.

 (6) The Ministry of Justice and the Ministry of the Interior, together with the Ministry of Social Affairs, shall arrange for persons suffering from tuberculosis to be sent for treatment pursuant to the procedure provided for in this Act after such persons are released from a penal institution, police detention house or detention cell.

§ 18.  Duties of Health Board upon prevention, surveillance and control of communicable diseases

 (1) The competent authority in the area of prevention, surveillance and control of communicable diseases shall be the Health Board which shall:
 1) conduct epidemiological investigations with the aim of ascertaining the circumstances under which persons suffering from a disease became infected and of determining the circumstances of the spread of the communicable disease, and, in the event of clusters of disease, shall provide instructions for the application of disease control measures;
 2) inform the population through the media of the occurrence of a communicable disease and the measures taken to control the outbreak of the disease;
 3) organise the distribution, the storage and transport of immunological preparations procured on the basis of Public Procurement Act and functioning of the cold chain;
 4) collect, analyse and publish data concerning immunisations;
 5) organise the surveillance of communicable diseases, including the sentinel surveillance, according to the relevant legislation of the European Union and recommendations of the World Health Organisation.

 (2) The competent authority in the area of epidemiological risk analysis and risk assessment of communicable diseases shall be the Health Board who shall determine and assess:
 1) tendencies of spread of communicable diseases;
 2) immunisation coverage.

 (3) The authorised authority upon participation in the international control of communicable diseases shall be the Health Board who shall handle the early warning and response system of the European Centre for Disease Prevention and Control in Estonia.

 (4) The Health Board shall be the liaison body authorised by the World Health Organisation and European Commission concerning biological agents in connection with the application of international medico-sanitary regulations.

 (5) The Health Board shall participate as the competent authority in the disease-specific epidemiological activities of the World Health Organisation and the European Centre for Disease Prevention and Control, including in the international disease control programmes by performing the role of the national reference laboratory in the relevant testing areas of communicable diseases.
[RT I, 04.12.2015, 1 – entry into force 14.12.2015]

 (6) In performing the functions prescribed by this Act, the Health Board shall co-operate with county governments and local governments for the prevention, surveillance of communicable diseases and to prevent and control the spread of communicable diseases.

 (7) When participating in the international control of communicable diseases, the Health Board is required to inform other states of the occurrence of a communicable disease and the measures taken to control the outbreak of the disease. The requirements and procedure for international co-operation in the control of communicable diseases and the provision of information related thereto shall be established by the Government of the Republic.
[RT I 2009, 49, 331 – entry into force 01.01.2010]

 (8) The Health Board shall provide health services pursuant to the provisions governing the provision of specialised medical care set out in the Health Services Organisation Act. Upon the provision of specialised medical care, the form requirement of a legal person provided for in subsection 21 (1) of the Health Services Organisation Act shall not be applied to the Health Board.
[RT I, 04.12.2015, 1 – entry into force 14.12.2015]

§ 19.  Suspicion of communicable disease and diagnosis of disease

 (1) Suspicion of a communicable disease is raised if a person exhibits clinical symptoms characteristic of the communicable disease or if a person has been in direct or indirect contact with an infected person or animal. Suspicion of a communicable disease may be confirmed by laboratory test findings.

 (2) Physicians are required to inform the local agency of the Health Board immediately of any suspicion of an extremely dangerous communicable disease.

 (3) Local agencies of the Health Board are required to inform the Health Board immediately of any suspicion of the epidemic spread of a communicable disease.
[RT I 2010, 41, 240 – entry into force 01.09.2010]

 (4) Microbiology, virology and parasitology laboratories engaged in detecting human pathogens, and research laboratories engaged in scientific research in those fields are required to inform the Health Board immediately of any suspicion or diagnosis of an extremely dangerous communicable disease.

 (5) The information specified in subsections (2)–(4) of this section shall be communicated together with personal data identifying the data subject.

 (51) Microbiology, virology and parasitology laboratories engaged in detecting human pathogens are required to forward testing material for additional testing to a reference laboratory engaged in the relevant testing area. Upon the collection, preservation and transportation of testing material, the laboratory shall adhere to the instructions prepared by the reference laboratory.
[RT I, 04.12.2015, 1 – entry into force 14.12.2015]

 (6) The Health Board has the right to forward the testing material needed for diagnosis of communicable diseases to a relevant foreign laboratory or an international reference laboratory without adding personal data identifying the data subject.

§ 20.  Registration of cases of communicable diseases

 (1) Cases of communicable disease shall be registered in the register of communicable diseases, and the database comprised of such information shall be used to prevent communicable diseases and determine the tendencies of their spread.

 (2) The register of communicable diseases is a state register founded by the Government of the Republic pursuant to the Public Information Act on the proposal of the minister responsible for the area. The chief processor of the register of communicable diseases is the Ministry of Social Affairs.
[RT I 2007, 12, 66 – entry into force 01.01.2008]

 (3) Information regarding suspicion of a communicable disease, diagnosis of such a disease, the factors affecting the risk of becoming infected, and the prevention of infection shall be registered at the place where the person seeks medical help.

§ 21.  Communication of information

 (1) Health care providers shall communicate information concerning any suspicion of a communicable disease, diagnosis of such a diseases, the factors affecting the risk of becoming infected, and the prevention of infection to the Health Board on the basis and pursuant to the procedure established by this Act.

 (2) Health care providers shall immediately inform the Health Board of any suspicion of the rapid spread of food poisoning or disease, or the rapid spread of disease.

 (3) Local agencies of the Health Board shall inform the Health Board of the occurrence of a communicable disease and the measures taken to control the disease. Any occurrence of the plague, cholera, yellow fever and viral hemorrhagic fevers shall be reported to the alarm centre.
[RT I, 29.12.2011, 1 – entry into force 01.01.2012]

 (4) Laboratories engaged in microbiological, virological, parasitological and serological testing shall communicate laboratory test findings to the physician who submitted the tested material. The findings of laboratory tests conducted in order to determine the presence of an infection subject to registration shall be sent to the Health Board of the residence of the tested person.

 (5) The Ministry of Defence, the Ministry of the Interior and the Ministry of Justice shall inform the Health Board of the occurrence of communicable diseases in the agencies in their area of government and of the risk factors related to the diseases pursuant to the procedure provided for in this Act.
[RT I, 04.12.2015, 1 – entry into force 14.12.2015]

 (6) The agencies in the area of government of the Ministry of Rural Affairs and the agencies governed thereby shall inform the Health Board of the detection of zoonotic agents in food and in the various stages of the handling of food, and zoonoses diagnosed on animals.
[RT I, 04.12.2015, 1 – entry into force 14.12.2015]

 (6¹) Data on suspicion or diagnosis of a communicable disease shall be communicated together with personal data identifying the data subject, if necessary. The list of communicable diseases which require the communication of data together with the personal data identifying the data subject shall be established by a regulation of the Government of the Republic.

 (7) The procedure for submission of the data prescribed in subsections (1), (4), (5) and (6) of this section and the composition thereof shall be established by a regulation of the Government of the Republic.

 (8) The Health Board is required to inform the World Health Organisation of the diagnosis of any of the communicable diseases specified in international agreements within twenty-four hours after such diseases are diagnosed.
[RT I 2009, 49, 331 – entry into force 01.01.2010]

 (9) The Health Board is required to inform the agency for the epidemiological surveillance and control of communicable diseases in the European Union of the diagnosis of any of the communicable diseases included in the list prepared by the European Commission.

§ 22.  Requirements for control of communicable diseases

 (1) The requirements for the control of communicable diseases shall set out the instructions for the control of communicable diseases and for prevention of the epidemic spread thereof.

 (2) The requirements for the control of communicable diseases are mandatory for health care professionals, health protection officials, persons present in infected areas and other persons involved in the control of communicable diseases as a result of their duties.

 (3) The requirements for the control of communicable diseases shall be established by a regulation of the minister responsible for the area.

 (4) The procedure for treating patients suffering from drug-resistant tuberculosis who violate the treatment requirements shall be established by a regulation of the minister responsible for the area.

 (5) The Health Board shall develop measures for the control of communicable diseases which have not been previously recorded in Estonia and shall inform the persons concerned of such measures.

§ 23.  Surveillance, prevention and control of nosocomial infections

 (1) A nosocomial infection is an infection which a patient did not have before being admitted to or visiting a hospital or any other enterprise providing health care services and which is not a residual effect of the patient’s stay there but is a condition which the patient developed during his or her stay there or as a result of treatment received there and the symptoms of which develop during the patient’s stay or after leaving.

 (2) The measures for surveillance, prevention and control of nosocomial infections to be applied by health care providers and the procedure for communicating the corresponding information shall be established by a regulation of the minister responsible for the area.

 (3) The procedure for informing the Health Board of the findings of laboratory surveillance of nosocomial infections and test findings concerning the drug resistance of microbes, as carried out by microbiology and virology laboratories, shall be established by a regulation of the minister responsible for the area.

§ 24.  Obligations of employers in control of communicable diseases

  An employer is required to:
 1) create working conditions which are as safe from infection as possible for employees working in areas where there is a risk of becoming infected with a communicable disease;
 2) ensure that the requirements established for safety from infection are met at the workplace;
 3) ensure that employees in areas specified in clause (1) of this section are immunised and, if necessary, provided with preventive treatment;
 4) permit employees to undergo medical examinations for the detection of communicable diseases or carrier states and to receive emergency immunisations during working hours;
 5) prevent the spread of infectious agents upon the handling of raw materials and finished products;
 6) ensure that infectious waste is rendered harmless.

Chapter 5 PREVENTION OF EPIDEMIC SPREAD OF COMMUNICABLE DISEASES  

§ 25.  Requirements for prevention of spread of extremely dangerous communicable diseases

 (1) In the event of suspicion or diagnosis of an extremely dangerous communicable disease, the minister responsible for the area may, on the proposal of the Health Board, form a state infection control committee and a county governor may, on the proposal of the head of the Health Board, form a county infection control committee at the focus of the disease to eliminate the risk of infection and prevent the spread of the communicable disease.

 (2) The procedure and conditions for the prevention of extremely dangerous communicable diseases on the Estonian state border shall be established by a regulation of the Government of the Republic.

§ 26.  Prevention of spread of communicable diseases during emergency situations

  Measures to prevent the spread of communicable diseases during an emergency situation shall be applied in accordance with the provisions of the Emergency Situation Act.
[RT I 2009, 39, 262 – entry into force 24.07.2009]

§ 27.  Establishment and termination of quarantine

 (1) Quarantine is a restriction of the movement of persons, goods and vehicles and of the provision of services which is established with the aim of preventing any extremely dangerous communicable disease from spreading outside the focus of the disease.

 (2) For the purposes of this Act, the focus of a disease is a delimited territory containing persons suffering from a communicable disease and persons suspected of being infected and where intensified surveillance over the residents is exercised by the health protection authorities.

 (3) Quarantine is established by a written order of the county governor on the proposal of the director general of the Health Board.

 (4) Quarantine requirements and the procedure for compliance therewith shall be established by a regulation of the minister responsible for the area.

 (5) Quarantine is terminated by a written order of the county governor on the proposal of the director general of the Health Board after the spread of the communicable disease has been prevented, the requirements for the control of the communicable disease have been fulfilled and the focus of the disease has been rendered harmless.

 (6) The establishment of quarantine requirements and the termination thereof shall be made public through the media.

§ 28.  Prevention of epidemic spread of communicable diseases

 (1) The risk arising from the epidemic spread of a communicable disease shall be determined by the Health Board on the basis of epidemiological, laboratory and clinical information submitted thereto.

 (2) In order to prevent the epidemic spread of a communicable disease and on the proposal of the head of the Health Board, a county governor or a rural municipality or city mayor may:
 1) order schools and child care and social welfare institutions to be closed temporarily;
 2) demand that disinfection, eradication of insect vermin, pest extermination or cleaning be organised;
 3) demand that persons undergo medical examinations.

 (3) The head of a child care or social welfare institution may temporarily close the institution after obtaining approval therefor from the head of the Health Board.

§ 29.  [Repealed - RT I 2004, 27, 177 – entry into force 01.05.2004]

Chapter 6 HANDLING OF INFECTIOUS MATERIAL  

§ 30.  Handling of infectious material

 (1) Material is infectious if it contains bacteria, viruses, microscopic fungi, infected cell cultures, human internal parasites or other bioactive agents causing communicable diseases.

 (2) For the purposes of this Act, the handling of infectious material is the taking of samples from material specified in subsection (1) of this section, the transport, processing, testing and storage of such material and the rendering of such material harmless.

 (3) Upon the handling of infectious material, it shall be ensured that the infection is prevented from spreading. The procedure for handling infectious material shall be established by a regulation of the minister responsible for the area.

 (4) Infectious material may be handled by health care providers and other legal and natural persons to whom the Health Board has issued an activity licence for the handling of infectious material pursuant to the procedure provided for in §§ 32–36 of this Act.
[RT I 2009, 49, 331 – entry into force 01.01.2010]

 (5) The requirements for the laboratory facilities, installations and equipment of persons handling infectious material and the safety measures to be applied shall be established by a regulation of the minister responsible for the area.

 (6) A laboratory worker responsible for the testing of infectious material must have the qualifications of a physician or biologist.

§ 31.  [Repealed - RT I 2009, 49, 331 – entry into force 01.01.2010]

§ 32.  Application for activity licence for handling of infectious material from Health Board

 (1) In order to obtain an activity licence for the handling of infectious material, a person specified in subsection 30 (4) of this Act shall submit the following information and documents to the Health Board:
[RT I 2009, 49, 331 – entry into force 01.01.2010]
 1) an application which sets out the name of the applicant and the location and address of the place of business;
 2) copies of the memorandum of association or foundation resolution and of the articles of association or partnership agreement of the legal person being founded;
 3) in the case of a sole proprietor, the name, personal identification code, residence and business name of the undertaking;
 4) a list of the testing services regarding which the activity licence is applied for;
 5) copies of the professional certificates of employees to be engaged in the testing of infectious material;
 6) information on the laboratory facilities, installations and equipment;
 7) information on the safety measures to be applied;
 8) the telecommunications numbers of the applicant.

 (2) Before submitting an application, an applicant for an activity licence shall pay the state fee.

 (3) If an applicant for an activity licence fails to submit any information or documents specified in subsection (1) of this section or if the application contains other deficiencies, the Health Board shall set a term for the applicant to eliminate the deficiencies.

 (4) The date on which the Health Board receives all the information and documents prepared in accordance with the requirements specified in subsection (1) of this section is deemed to be the date of submission of an application.

§ 33.  Decision on issue of activity licence

  The issuer of activity licences shall check the documents and information submitted by an applicant and shall make a decision to issue or to refuse to issue an activity licence not later than within one month as of submission of the documents and information specified in § 32 of this Act.

§ 34.  Issue of activity licence

 (1) Activity licences are issued by the Health Board.

 (2) An activity licence shall be issued within ten working days as of the corresponding decision being made.

 (3) A decision to issue an activity licence shall be published in the official publication Ametlikud Teadaanded.

§ 35.  Information and conditions set out in activity licence

  An activity licence shall set out:
 1) the name, place of business and address of the holder of the activity licence and, in the case of a sole proprietor, also his or her personal identification code, residence and business name;
 2) the number and date of issue of the activity licence;
 3) a list of testing services.

§ 36.  Refusal to issue activity licence

 (1) An activity licence shall not be issued if the applicant for the activity licence:
 1) has not submitted all the documents and information specified in subsection 32 (1) of this Act, or if the application contains other deficiencies which the applicant has failed to eliminate within the term specified in subsection 32 (3) of this Act;
 2) does not comply with the requirements established for handlers of infectious material;
 3) submits false information;
 4) is bankrupt.

 (2) The issuer of activity licences shall notify an applicant for an activity licence of its refusal to issue the activity licence in writing within ten working days as of the decision to refuse to issue the licence being made. The notice shall set out the reasons for the refusal to issue the activity licence together with a reference to the corresponding provisions of law.

§ 37.  Validity of activity licence

  Activity licences shall be valid for five years as of the issue thereof.

§ 38.  Revocation of activity licence

 (1) The issuer of an activity licence shall revoke the activity licence if:
 1) so requested by the holder of the activity licence;
 2) the facilities, installations or equipment of the laboratory or the safety measures to be applied do not conform to the requirements established on the basis of subsection 30 (5) this Act;
 3) the qualifications of employees responsible for the testing of infectious material do not conform to the requirements provided for in subsection 30 (6) of this Act;
 4) the requirements established on the basis of subsection 30 (3) of this Act are not complied with upon the handling of infectious material;
 5) the testing specified in the activity licence has not commenced within a period of one year as of the issue of the licence;
 6) the holder of the activity licence engages in testing which is not listed in the activity licence issued thereto.

 (2) A decision to revoke an activity licence shall set out:
 1) the name, place of business and address of the holder of the activity licence and, in the case of a sole proprietor, his or her name, personal identification code, residence and business name;
 2) the number and date of issue of the activity licence;
 3) the circumstances which caused the activity licence to be revoked and a reference to the provision of law pursuant to which the activity licence is revoked;
 4) the date on which the decision was made;
 5) the name, official title and signature of the person who made the decision.

 (3) The holder of an activity licence shall be notified of a decision to revoke the activity licence within five working days as of the decision being made. The decision to revoke the activity licence shall be published in the official publication Ametlikud Teadaanded.

§ 39.  Partial revocation of activity licence

 (1) If the bases for revocation of an activity licence exist only with regard to some of the tests, the activity licence may be partially revoked by restricting the list of tests set out in the licence.

 (2) Upon partial revocation of an activity licence, the corresponding decision shall, in addition to the information specified in subsection 38 (4) of this Act, set out the tests with regard to which the decision to revoke the activity licence applies.

 (3) The holder of an activity licence shall be notified of a decision to partially revoke the activity licence within five working days as of the decision being made. A decision to partially revoke an activity licence shall be published in the official publication Ametlikud Teadaanded.

§ 40.  Application for new activity licence

 (1) The holder of an activity licence shall apply for a new activity licence if:
 1) the licence expires;
 2) the holder of the licence wishes to amend the list of testing services set out in the licence.

 (2) A new activity licence shall be issued pursuant to the procedure provided for in §§ 32–36 of this Act.

 (3) In order to apply for a new activity licence, an applicant shall submit that information and those documents specified in § 32 of this Act which does not or do not contain information already known to the Health Board.

§ 41.  Reference laboratory

  [RT I, 04.12.2015, 1 – entry into force 14.12.2015]

 (1) For the purposes of this Act, a reference laboratory is a laboratory which provides reference service in the testing areas specified in this section by using the high sensitivity and specificity diagnostics method.

 (2) A laboratory which has been accredited in the relevant testing area by an Estonian or foreign internationally recognised accreditation institution may operate as a reference laboratory.

 (3) The testing areas of a reference laboratory are:
 1) HI-viruses;
 2) influenza and other respiratory viruses;
 3) other viruses;
 4) causative agents of tuberculosis and mycobacteriosis;
 5) causative agents of sexually transmitted communicable diseases;
 6) causative agents of invasive bacterial communicable diseases;
 7) causative agents of other bacterial communicable diseases;
 8) antimicrobial resistance.

 (4) The functions of a reference laboratory upon the provision of reference service in its testing area are to:
 1) organise and coordinate the quality management of laboratory diagnostics;
 2) counsel other laboratories concerning the method of laboratory diagnostics;
 3) prepare and update the instructions for the collection, preservation and transportation of laboratory testing material;
 4) confirm laboratory diagnoses, if necessary;
 5) identify the pathogenic agents forwarded for testing, and the collection and preservation thereof;
 6) collect and analyse laboratory surveillance data;
 7) forward the test results to the register of communicable diseases according to subsections § 21 (6¹ ) and (7) of this Act;
 8) cooperate with the international reference laboratories and institutions of the relevant testing areas.

 (5) The provision of reference service in the testing areas specified in this section shall be organised by the Health Board. For the provision of reference service, the director general of the Health Board may enter into a contact for five years with a laboratory corresponding to the requirements of this Act.
[RT I, 04.12.2015, 1 – entry into force 14.12.2015]

Chapter 7 FINANCING OF PREVENTION, SURVEILLANCE AND CONTROL OF COMMUNICABLE DISEASES  
[RT I 2009, 49, 331 - entry into force 01.01.2010]

§ 42.  Financing of prevention, surveillance and control of communicable diseases

  [RT I 2009, 49, 331 – entry into force 01.01.2010]

 (1) The following shall be financed from the state budget through the Ministry of Social Affairs:
 1) the acquisition of vaccines and immunoglobulins needed to comply with the immunisation schedule and for emergency immunisation, and the storage and transport of vaccines, functioning of the cold chain and studies of the immunity background of the population;
 2) the fulfilment of government orders placed with reference laboratories.

 (2) Additional immunisation of servicemen sent on missions abroad shall be financed from the state budget through the Ministry of Defence.

 (3) Immunisations which are not included in the immunisation schedule and which are administered at the request of the patient or at the recommendation of the physician shall not be financed from the state budget.

 (4) An employer shall finance:
 1) immunisation and preventive treatment to protect the health of employees who are at risk of becoming infected due to the particular nature of their work;
 2) additional medical examinations of employees in areas where the particular nature of the work may contribute to the transmission of communicable diseases.
[RT I, 04.12.2015, 1 – entry into force 14.12.2015]

 (5) Employers are not required to finance the screening of employees for communicable diseases before the employees commence work in an area where the particular nature of the work may contribute to the transmission of communicable diseases.

 (6) The prevention and control of communicable diseases may be financed from rural municipality or county government budgets.

 (7) The prevention and control of communicable diseases may be financed from the health insurance budget.
[RT I, 04.12.2015, 1 – entry into force 14.12.2015]

§ 43.  Financing of prevention of epidemic spread of communicable diseases

 (1) Prevention of the epidemic spread of communicable diseases shall be financed from the state budget according to the order of the Government of the Republic.
[RT I, 04.12.2015, 1 – entry into force 14.12.2015]

 (2) Expenditure shall not be compensated for pursuant to the procedure provided in subsection (1) of this section if:
 1) when making of the expenditure, the legal person or natural person violated the requirements established by this Act or legislation issued on the basis thereof or the precept of a health protection official;
 2) such expenditure was made before any suspicion of the epidemic spread of a communicable disease arose.

Chapter 8 STATE SUPERVISION AND LIABILITY  
[RT I, 13.03.2014, 4 - entry into force 01.07.2014]

§ 44.  State supervision

  [RT I, 13.03.2014, 4 – entry into force 01.07.2014]
State supervision over compliance with the requirements arising from this Act and legislation established on the basis thereof shall be exercised by the Health Board (hereinafter law enforcement agency).
[RT I, 04.12.2015, 1 – entry into force 14.12.2015]

 (2) Supervision over compliance with the requirements arising from clauses 13 (1) 1) and 2) of this Act shall be exercised by the Veterinary and Food Board. Supervision over the handlers of drinking water shall be exercised by the Veterinary and Food Board to the extent provided for in the Food Act.
[RT I, 04.12.2015, 1 – entry into force 14.12.2015]

§ 45.  Special state supervision measures

  [RT I, 13.03.2014, 4 – entry into force 01.07.2014]
For the execution of state supervision provided for in this Act, the law enforcement agency may apply the special state supervision measures provided for in §§ 30, 31, 32, 49 and 50 of the Law Enforcement Act on the basis of and pursuant to the procedure provided for in the Law Enforcement Act.
[RT I, 13.03.2014, 4 – entry into force 01.07.2014]

§ 45¹.  Limit of penalty payment

  In the event of failure to comply with a precept, the upper limit of penalty payment imposed pursuant to the procedure provided for in the Substitutive Enforcement and Penalty Payment Act shall be 640 euros.
[RT I, 13.03.2014, 4 – entry into force 01.07.2014]

§ 46.  Violation of requirements for control of communicable diseases

 (1) Violation of the requirements for the control of communicable diseases or for the handling of infectious material is punishable by a fine of up to 200 fine units.

 (2) The same act, if committed by a legal person, is punishable by a fine of up to 3200 euros.
[RT I 2010, 22, 108 – entry into force 01.01.2011]

§ 47.  Delay in submission of information

 (1) Failure to communicate information related to communicable diseases in time is punishable by a fine of up to 50 fine units.

 (2) The same act, if committed by a legal person, is punishable by a fine of up to 640 euros.
[RT I 2010, 22, 108 – entry into force 01.01.2011]

§ 48.  Non-compliance with terms for immunisations

 (1) Failure to conduct, in time, the immunisations prescribed to prevent the epidemic spread of a communicable disease is punishable by a fine of up to 100 fine units.

 (2) The same act, if committed by a legal person, is punishable by a fine of up to 1300 euros.
[RT I 2010, 22, 108 – entry into force 01.01.2011]

§ 49.  Proceedings

 (1) [Repealed - RT I, 12.07.2014, 1 – entry into force 01.01.2015]

 (2) The body conducting extra-judicial proceedings concerning the misdemeanours provided in §§ 46–48 of this Act shall be the Health Board.
[RT I 2009, 49, 331 – entry into force 01.01.2010]

Chapter 9 IMPLEMENTING PROVISIONS  

§ 50.  Right to handle infectious material

 (1) Specialised medical care providers and other persons providing laboratory services who are engaged in the handling of infectious material are required to apply for the right to handle infectious material within two years as of the entry into force of this Act.

 (2) A specialised medical care provider or other person providing laboratory services loses the right to handle infectious material if the person has not submitted an application to obtain the right to handle infectious material within the term specified in subsection (1) of this section or if the authority which grants the right to handle infectious material refuses to grant that right.

§ 51. – § 53. [Omitted from this text.]

§ 54.  Entry into force of Act

  This Act enters into force on 1 November 2003, except for:
 1) subsections 20 (1) and (2) of this Act which enter into force on 1 July 2004;
 2) subsection 9 (2) of this Act which enters into force on 1 November 2004;
 3) section 11 of this Act which enters into force on 1 May 2005;
 4) subsection 21 (9) of this Act which enters into force as of Estonia’s accession to the European Union.